American Society of Interventional Pain Physicians | January 30, 2019
One Day Ultrasound Course February 21, 2019
Orlando, FL
Limited Hotel Rooms Available
3 Choices in February!
Review Courses and Cadaver Labs
Feb 22-24 2019, Orlando, FL
Abstract Submission Deadline February 18

Abstract submissions are now being accepted for the 2019 ASIPP Annual Meeting Abstract and Poster Contest. The top 10 abstracts selected by our panel will be presented at the annual meeting. The top 25 abstracts will be presented as electronic posters in view for all our attendees.

Click HERE to submit. Deadline is Feb. 18

July 13 - July 14 | Memphis, TN
The American Board of Interventional Pain Physicians ( ABIPP ) has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management
profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become ABIPP certified.
ABIPP now offers the only competency certification program for regenerative medicine.
For complete information about the examination requirements and to obtain an application packet, visit or call 270-554-9412 x4217 or by email at

July 13
July 13-14
July 14
ABIPP Competency Exam

July 13
Combined CSM/CCPM Exam for ABIPP Path
July 13
Competency Exam in Controlled Substance Managemen

July 13
Competency Exam in Coding, Compliance, and
Practice Management

July 13-14
Regenerative Medicine Competency Exam
July 13-14
Endoscopic Lumbar Decompression Competency Exam

939 Ridge Lake Blvd. | Memphis, TN 38120
The cut-off date for our room block with discounted rates is on June 10, 2019 or until sold out, whichever occurs first.
Election Results: ASIPP Board of Directors 2019-2020 

We would like to extend our sincere appreciation for the interest and participation of all those who were nominated. We congratulate the ones who have been elected.
The newly elected board effective May 3, 2019 are as follows:
Chairman of the Board and CEO
Laxmaiah Manchikanti, MD 
Incoming President 
Sudhir Diwan, MD 
Harold Cordner, MD 
First Executive Vice-President 
Amol Soin, MD 
Second Executive Vice-President
Sheri Albers, DO 
Vice President-Strategic Affairs
Sukdeb Datta, MD 
Frank Falco, MD 
Sanjay Bakshi, MD 
Lifetime Directors
Laxmaiah Manchikanti, MD, Cyrus E. Bakhit, MD , Vijay Singh, MD
Academic Directors (4 positions)
Joshua Hirsch, MD , Christopher Gharibo, MD , Sal Abdi, MD , Jay Grider, DO 
Young Physician Directors (4 positions) 
Jessica Jameson, MD , Helen Blake, MD , Kunj Patel, MD , Kartic Rajput, MD 
Resident / Fellow Board member (1 position) 
Yu Chiu, MD 
Directors-at-Large (5 positions)
Devi Nampiaparampil, MD , Ricardo Buenaventura, MD , Dharam Mann, MD , Steve Aydin, DO , Deborah Tracy, MD 
Directors Emeritus (2 positions) 
Ramsin Benyamin, MD , Standiford Helm, MD 
AMA House of Delegates/CPT/RUC
Lee Snook, MD, AMA Delegate 
Sachin "Sunny" Jha, MD , AMA CPT Advisory Committee, AMA Alternate Delegate
Michael Lubrano, MD , AMA RFS Representative, AMA RUC Member 
Pain Physician Journal
Alan David Kaye, MD PhD. Editor-in-Chief
IPM Reports
Kenneth Candido, MD, Editor-in-Chief
American Board of Interventional Pain Physicians (ABIPP)
Mark Boswell, MD PhD, Executive Director

Regenerative Medicine and Antithrombotic Guidelines Now Available

Responsible, Safe, and Effective Use of Biologics in the Management of Low Back Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines

Responsible, Safe, and Effective Use of Antithrombotics and Anticoagulants in Patients Undergoing Interventional Techniques: American Society of Interventional Pain Physicians (ASIPP) Guidelines

ASIPP Webinar Feb. 6: 2019 Changes for Your Pain Practice- Are You Prepared

A constant for all practices is billing for evaluation and management services. It has been 20 years since any changes have been made to documentation requirements and the methodologies to determine the correct level of service to report. Sweeping changes have been proposed, to be implemented starting in 2019 and continuing through 2021.  Tune in to this webinar to learn how these reforms may impact work volume, documentation efficiency, as well as revenue for your pain practice.

Wednesday, February 6, 2019
11am-12:30pm CST
1.5 hrs

Judith Blaszczyk

Devona Slater
President, Auditing for Compliance and Education, Inc.

Click Here to Register

DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access

The U.S. Drug Enforcement Administration has  taken some cannabidiol out of the most restrictive class  of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.
It’s a decision that immediately affects CBD producers but also signals the agency’s first admission that the plant has medical value.
The DEA announced Thursday that drugs including CBD with THC content below 0.1% are now considered Schedule 5 drugs, as long as they have been approved by the U.S. Food and Drug Administration.

Interventional Pain Management Reports is an Open Access online journal, a peer-reviews journal dedicated to the publication of case reports, brief commentaries and reviews and letters to the editor. It is a peer-reviewed journal written by and directed to an audience of interventional pain physicians, clinicians and basic scientists with an interest in interventional pain management and pain medicine. 

Interventional Pain Management Reports is an official publication of the American Society of Interventional Pain Physicians (ASIPP) and is a sister publication of Pain Physician . Interventional Pain Management Reports Interventional Pain Management Reports is an open access journal, available online with free full manuscripts.  

The benefits of publishing in an open access journal that has a corresponding
print edition journal are:  
  • Your article will have the potential to obtain more citations.
  • Your article will be peer-reviewed and published faster than other journals.
  • Your article can be read by a potentially much larger audience compared with traditional subscription-only journals.  
  • Open Access journals are FREE to view, download and to print.

So submit today your:
  • Case Reports
  • Technical Reports
  • Editorials
  • Short Perspectives

Pain Physician
January/February 2019 Issue Features

Sjors H. Wagemakers, MD, Joanne M. van der Velden, MD, PhD, A. Sophie Gerlich, MD, Alinde W. Hindriks-Keegstra, MD, Jacqueline F.M. van Dijk, PhD, and Joost J.C. Verhoeff, MD, PhD.
Cui Zhiyong, MD, Tian Yun, MD, Feng Hui, MD, Yang Zhongwei, MD, and Liu Zhaorui, MD.

Zung Vu Tran, PhD, Anna Ivashchenko, MPH, and Logan Brooks, BA.
Peng-Fei Wu, BD, Ya-Wei Li, MD, Bing Wang, MD, Bin Jiang, BD, Zhi-Ming Tu, BD, and Guo-Hua Lv, MD.

Parisa Nejati, MD, Afsaneh Safarcherati, MD, and Farshid Karimi, MD.

CMS launches app to outline services covered under Medicare

CMS has launched the "What's Covered" app to let Original Medicare patients and caregivers see whether Medicare covers a medical item or service.
Original Medicare is coverage managed by the federal government. Generally, there's a cost for each service.
Consumers can use the app to more easily get accurate Original Medicare coverage information in the physician's office, hospital or anywhere else they use their mobile device.
The app is part of the CMS eMedicare initiative launched last year to provide beneficiaries with cost and quality information. 

Limited Benefits of TNF-α Inhibitors for Chronic Low Back Pain

Anticytokine treatments may be ineffective in alleviating  chronic low back pain  with or without sciatica, according to a systematic review published in  Pain Medicine .
For this narrative literature review on the use of biologic agents for low back pain and sciatica, investigators used search terms that included anti-tumor necrosis factor (TNF), anti-nerve growth factor (NGF), and growth factors, yielding a total of 10 studies.
The use of TNF-α inhibitors to reduce and improve pain in chronic low back pain with or without sciatica was not supported by results from the randomized controlled trials and the meta-analysis that were reviewed. Results from observational studies indicated benefits associated with TNF-α inhibition for pain reduction. 

Characteristics of Physicians Excluded from Medicare Reimbursement Programs Examined

During the 10-year period between 2007 and 2017, a noticeable increase in the number of physicians excluded from Medicare and state public insurance reimbursement participation due to fraud, waste, or abuse was observed, according to results of an analysis published in  JAMA Network Open .
Older male physicians who practiced family medicine, internal medicine, psychiatry, or surgery were more likely to have been excluded during this study period.
Physicians who were excluded from Medicare and state public insurance programs between the years 2007 and 2017 were matched to a cross-sectional database provided by Doximity. Study researchers evaluated the share of physicians who were excluded in each US state and also examined linear trends of exclusions during the 10-year period. Physician variables, including legal factors (eg, fraud, health crimes, and substance abuse) and characteristics (eg, age, sex, allopathic vs osteopathic degree, medical school attended, ranking of that medical school, medical school faculty affiliation, practice state, practice location, and specialty) were also examined to identify factors associated with exclusion.

State Society News 

July 12-14, 2019
GSIPP 2019 - 15th Annual Meeting & Pain Summit
The Cloister Hotel at Sea Island
Sea Island, GA
For more information, contact Karrie Kirwan at or Tara Morrison at or 770-613-0932.

July 26-28, 2019
PAIN 2019
West Virginia Society of Pain Physicians
Loews Miami Beach, FL

Send in your state society meeting news to Holly Long,
ASIPP | Pain Physician Journal | Phone | Fax | Email